Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors

被引：1

作者：

Bahekar, Rajesh ^{[1
]}

Dave, Bhushan ^{[1
,2
]}

Soman, Shubhangi ^{[2
]}

Pater, Dipam ^{[1
]}

Chopade, Rajendra ^{[1
]}

Funde, Radhika ^{[1
]}

Kumar, Jeevan ^{[3
]}

Sachchidanand, S. ^{[3
]}

Giri, Poonam ^{[4
]}

Chatterjee, Abhijit ^{[4
]}

Mahapatra, Jogeswar ^{[4
]}

Vyas, Purvi ^{[5
]}

Ghoshdastidar, Krishnarup ^{[5
]}

Bandyopadhyay, Debdutta ^{[5
]}

Desai, Ranjit C. ^{[1
]}

机构：

[1] Zydus Res Ctr, Dept Med Chem, NH 8A Moraiya, Ahmadabad 382210, Gujarat, India

[2] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Chem, Vadodara 390002, India

[3] Zydus Res Ctr, Dept Bioinformat, NH 8A Moraiya, Ahmadabad 382210, Gujarat, India

[4] Zydus Res Ctr, Dept Pharmacol, NH 8A Moraiya, Ahmadabad 382210, Gujarat, India

[5] Zydus Res Ctr, Dept Cell Biol, NH 8A Moraiya, Ahmadabad 382210, Gujarat, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 11期

关键词：

PI3K inhibitors; Inflammatory and autoimmune diseases; Rheumatoid arthritis; Imidazo-quinolinones; Design; Synthesis and biological study; PHOSPHOINOSITIDE; 3-KINASE; IDELALISIB;

D O I：

10.1016/j.bmcl.2019.04.007

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

PI3K delta is implicated in various inflammatory and autoimmune diseases. For the effective treatment of chronic immunological disorders such as rheumatoid arthritis, it is essential to develop isoform selective PI3K delta inhibitors. Structure guided optimization of an imidazo-quinolinones based pan-PI3K/m-TOR inhibitor (Dactolisib) led to the discovery of a potent and orally bioavailable PI3K delta isoform selective inhibitor (10h), with an improved efficacy in the animal models.

引用

页码：1313 / 1319

页数：7

共 50 条

[21] The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)
Pike, Kurt G.
Barlaam, Bernard
Cadogan, Elaine
Campbell, Andrew
Chen, Yingxue
Colclough, Nicola
Davies, Nichola L.
de-Almeida, Camila
Degorce, Sebastien L.
Didelot, Myriam
Dishington, Allan
Ducray, Richard
Durant, Stephen T.
Hassall, Lorraine A.
Holmes, Jane
Hughes, Gareth D.
MacFaul, Philip A.
Mulholland, Keith R.
McGuire, Thomas M.
Ouvry, Gilles
Pass, Martin
Robb, Graeme
Stratton, Natalie
Wang, Zhenhua
Wilson, Joanne
Zhai, Baochang
Zhao, Kang
Al-Huniti, Nidal
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (09) : 3823 - 3841
[22] Two-step synthesis of 3-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones
Scott, Jeremy P.
SYNLETT, 2006, (13) : 2083 - 2086
[23] Synthesis of 1,3-dialkyl-5-(pyrrol-1-yl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones
N. N. Smolyar
D. A. Lomov
Ya. S. Borodkin
S. V. Gresko
Russian Journal of Organic Chemistry, 2009, 45 : 796 - 797
[24] Synthesis of 1,3-dialkyl-5-(pyrrol-1-yl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones
Smolyar, N. N.
Lomov, D. A.
Borodkin, Ya. S.
Gresko, S. V.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2009, 45 (05) : 796 - 797
[25] Discovery of imidazo [4,5-c]pyridin-2-ones as selective inhibitors of DNA-dependent protein kinase and effective radiosensitizers
不详
CANCER RESEARCH, 2024, 84 (01)
[26] The discovery of imidazo[4,5-c]pyridine-2-ones as selective inhibitors of DNA-dependent protein kinase and effective radiosensitisers
Hay, M.
Hong, C.
Liew, L.
Dickson, B.
Wong, W.
O'Brien-Gortner, S.
Airey, R.
Wilson, W.
Jamieson, S.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S62 - S62
[27] 1-(2-methylpropyl)-1H-imidazo[4,5-c]-quinolin-4-amine
Cheng, J
Liu, ZM
Yang, GF
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O2638 - O2639
[28] 1H-imidazo[4,5-c]quinoline derivatives as novel potent TNF-α suppressors:: Synthesis and structure-activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines
Izumi, T
Sakaguchi, J
Takeshita, M
Tawara, H
Kato, K
Dose, H
Tsujino, T
Watanabe, Y
Kato, H
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (12) : 2541 - 2550
[29] Novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines. Potent angiotensin II receptor antagonists with high affinity for both the AT(1) and AT(2) subtypes
Mederski, WWKR
Dorsch, D
Osswald, M
Schwartz, H
Beier, N
Christadler, M
Minck, KO
Schelling, P
Schmitges, CJ
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (06) : 479 - 491
[30] Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors
Han, Sun-Young
Choi, Jie Won
Yang, Jeon
Chae, Chong Hack
Lee, Jongkook
Jung, Heejung
Lee, Kwangho
Ha, Jae Du
Kim, Hyoung Rae
Cho, Sung Yun
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2837 - 2842

← 1 2 3 4 5 →